Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01108263 · ClinicalTrials.gov registry record · Phase 4
Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
A Phase 4 study, sponsored by Georgetown University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT01108263: Clinical Trial Phase 4 study, sponsored by Georgetown University.
NCT01108263 is a Phase 4 study that was terminated before completion, run by Georgetown University. The registered enrollment target is 5 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01108263, a Phase 4 study, was terminated before completion, sponsored by Georgetown University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
* After determining if subjects meet the criteria to be included in the study they will be randomly placed in either Group 1 or 2 and patient will be blinded from randomization group. * Subjects will walk across a pressure plate to determine different areas of high pressure under the foot. This will be done before the INTEGRA application and at every other follow-up visit. * Both groups will be debrided and have pictures taken in the OR * Group 1 will have Integra Flowable Wound Matrix applied onto the wound in the OR and Group 2 will have the Integra Flowable Wound Matrix applied onto the wound and injected subcutaneously in the OR. * Subjects will be placed in a total contact cast at each visit. If wound healing occurs prior to 12 weeks, a final assessment visit will be done and the status of the healed ulcer will be assessed.
Interventions
- DRUG INTEGRA™ Flowable Matrix (Collagen)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-08 |
| Phase | Phase 4 |
Why NCT01108263 stopped before completion
NCT01108263 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which INTEGRA™ Flowable Matrix (Collagen) is the first listed.
NCT01108263 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01108263 about?
NCT01108263 is a clinical study titled "Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers". * After determining if subjects meet the criteria to be included in the study they will be randomly placed in either Group 1 or 2 and patient will be blinded from randomization group. * Subjects will walk across a pressure plate to determine different areas of high pressure under the foot. This will...
What is the current status of trial NCT01108263?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2010-06. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01108263?
The interventions under investigation include: INTEGRA™ Flowable Matrix (Collagen) (DRUG).
Who is sponsoring clinical trial NCT01108263?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01108263's enrollment target sits among peer trials
5 1989th of 2000 higher than 7 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia